MDGL- Madrigal Pharmaceuticals, Inc.

Name: Madrigal Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Madrigal Pharmaceuticals, Inc. (MDGL) has 11 insiders with recent SEC Form 4 filings, including 30 buys and 68 sells. MDGL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Taub Rebecca	452.2K	$231.29M	-
Dir	Friedman Paul A	199.7K	$102.12M	-
Dir	Baker Bros. Advisors LP	199.7K	$102.12M	-
CEO	Sibold William John	150.1K	$76.76M	-
Dir	Levy Richard S	27.3K	$13.98M	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 14, 2023	Baker Bros. Advisors LP59	Director	Buy	107,499	$146.99	$15,801,021.17	+0.4%	+38.3%	+101.4%
Mar 1, 2023	Waltermire Robert E.48	Senior VP, Chief Pharma Dev.	Sale+OE	10,000	$273.24	$2,732,438.36	-19.0%	+0.3%	-15.4%
Jan 17, 2023	Levy Richard S	Director	Sale+OE	22,489	$293.15	$6,592,685.55	-9.4%	-13.1%	-18.7%
Jan 3, 2023	Lynch Brian Joseph45	SVP And General Counsel	Sale+OE	13,000	$282.92	$3,677,976.60	-19.5%	-12.8%	-25.7%
Dec 23, 2022	Lynch Brian Joseph45	SVP And General Counsel	Sale+OE	7,000	$274.18	$1,919,230.69	-15.5%	-15.2%	-14.1%
Dec 23, 2022	Sukhija Remy	Chief Commercial Officer	Sale+OE	30,000	$274.14	$8,224,073.32	-11.9%	-15.2%	-14.1%
Aug 19, 2020	Bay City Capital LLC	10% Owner	Sell	30,000	$109.74	$3,292,195.83	-16.4%	-	-
Aug 19, 2020	Craves Fred B	Director, 10% Owner	Sell	30,000	$109.74	$3,292,195.83	-16.4%	-	-
Dec 13, 2019	Bay City Capital LLC	10% Owner	Sell	1,200,000	$105.47	$126,564,000.00	-22.3%	-	-
Dec 13, 2019	Craves Fred B	Director, 10% Owner	Sell	1,200,000	$105.47	$126,564,000.00	-22.3%	-	-

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC